Literature DB >> 6210710

Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.

J J Schier, R S Adelstein.   

Abstract

Human cardiac ventricular myosins were prepared from autopsy samples from nine adults, seven infants, and from surgical specimens from seven patients undergoing left ventricular septal myectomy for obstructive hypertrophic cardiomyopathy. Infant myosin differed from adult myosin in two important characteristics: (a) approximately 30% of the 27,000-dalton myosin light chain is replaced by a 28,000-dalton light chain, and (b) the actin-activated myosin MgATPase activity of infant myosin is significantly lower than that of adult myosin (64 nmol phosphate released/mg myosin per min vs. 124 nmol/mg per min at 37 degrees C). The K(+)-EDTA ATPase activity of the myosin measured in 0.5M KCl is also lower in infants (1,210 nmol/mg per min vs. 620 nmol/mg per min at 37 degrees C), but the Ca(++)-activated ATPase is not significantly different. There were no differences in enzymatic activity between the normal adult and cardiomyopathic myosins.A detailed study was performed to investigate possible variations in the structure of the myosin heavy chain in infant, adult, and cardiomyopathic samples. There were no significant differences between infant and normal adult, or between normal adult and cardiomyopathic myosins seen in pyrophosphate polyacrylamide gel electrophoresis, or peptide mapping using alpha-chymotrypsin, papain, or cyanogen bromide to generate peptides. These results suggest that isoenzymes of human ventricular myosin do not exist for the myosin heavy chain in the specimens examined from infants, adults, and patients with obstructive hypertrophic cardiomyopathy. The decreased actin-activated MgATPase activity found for infant myosin appears to be due solely to a partial replacement of the 27,000-dalton light chain of myosin with a 28,000-dalton light chain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6210710      PMCID: PMC370136          DOI: 10.1172/jci110521

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  An immunochemical difference between myosins from normal and hypertrophied rat hearts.

Authors:  K Schwartz; P Bouveret; J Bercovici; B Swynghedauw
Journal:  FEBS Lett       Date:  1978-09-01       Impact factor: 4.124

Review 2.  Stimulation of cardiac myosin adenosine triphosphatase in thyrotoxicosis.

Authors:  E Morkin
Journal:  Circ Res       Date:  1979-01       Impact factor: 17.367

3.  Enzymatic properties of the heavy meromyosin subfragment of cardiac myosin from normal and thyrotoxic rabbits.

Authors:  S K Banerjee; E G Kabbas; E Morkin
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

4.  Atrial and ventricular cardiac myosins contain different heavy chain species.

Authors:  I L Flink; J H Rader; S K Banerjee; E Morkin
Journal:  FEBS Lett       Date:  1978-10-01       Impact factor: 4.124

5.  Spectroscopic studies on invertebrate myosins and light chains.

Authors:  P D Chantler; A G Szent-Györgyi
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

6.  Evidence for a new cardiac myosin species in thyrotoxic rabbit.

Authors:  I L Flink; E Morkin
Journal:  FEBS Lett       Date:  1977-09-15       Impact factor: 4.124

7.  Structural differences in the heavy chains of rat ventricular myosin isoenzymes.

Authors:  J F Hoh; G P Yeoh; M A Thomas; L Higginbottom
Journal:  FEBS Lett       Date:  1979-01-15       Impact factor: 4.124

8.  SDS microslab linear gradient polyacrylamide gel electrophoresis.

Authors:  P T Matsudaira; D R Burgess
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

9.  Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement.

Authors:  J F Hoh; P A McGrath; P T Hale
Journal:  J Mol Cell Cardiol       Date:  1978-11       Impact factor: 5.000

10.  Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction.

Authors:  A G Morrow
Journal:  J Thorac Cardiovasc Surg       Date:  1978-10       Impact factor: 5.209

View more
  26 in total

1.  Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms.

Authors:  K A Palmiter; M J Tyska; D E Dupuis; N R Alpert; D M Warshaw
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

Review 2.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 3.  Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.

Authors:  Sharad Rastogi; Sudhish Mishra; Ramesh C Gupta; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

4.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

Authors:  M B Perryman; Q T Yu; A J Marian; A Mares; G Czernuszewicz; J Ifegwu; R Hill; R Roberts
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

5.  Regulation of fibre contraction in a rat model of myocardial ischemia.

Authors:  Young Soo Han; Ozgur Ogut
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

6.  Construction of a human ventricular cDNA library and characterization of a beta myosin heavy chain cDNA clone.

Authors:  M A Jandreski; C C Liew
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

Review 7.  Recent insights into cardiac hypertrophy and left ventricular remodeling.

Authors:  Risto Kerkela; Thomas Force
Journal:  Curr Heart Fail Rep       Date:  2006-04

8.  Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.

Authors:  M Kurabayashi; H Tsuchimochi; I Komuro; F Takaku; Y Yazaki
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 9.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

10.  Two different forms of beta myosin heavy chain are expressed in human striated muscle.

Authors:  M A Jandreski; M J Sole; C C Liew
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.